GenVoy-ILM™ T Cell Kit For mRNA, Ignite™

Scale Up Your Cell Therapy with Lipid Nanoparticles

Current gene delivery methods have significant challenges, hindering future innovations in cell therapies. Non-viral electroporation method can be harsh on cells, making it difficult to generate quality cells at high yields, whereas conventional viral vector delivery method is expensive and cumbersome to manufacture. Lipid nanoparticles (LNPs) enable researchers to establish a clinically-relevant and scalable method for ex vivo gene delivery and editing to advance the development of cell therapies.

GenVoy-ILM™ T Cell Kit for mRNA, Ignite is an off-the-shelf lipid nanoparticle (LNP) reagent mix optimized for the delivery of messenger RNA (mRNA) or Cas9 mRNA/sgRNA into activated human primary T cells. This kit is available in two sizes: 3 mL and 6 mL.